ZA200605478B - Production of hop extracts having oestrogenic and anti-proliferative bioactivity - Google Patents

Production of hop extracts having oestrogenic and anti-proliferative bioactivity

Info

Publication number
ZA200605478B
ZA200605478B ZA200605478A ZA200605478A ZA200605478B ZA 200605478 B ZA200605478 B ZA 200605478B ZA 200605478 A ZA200605478 A ZA 200605478A ZA 200605478 A ZA200605478 A ZA 200605478A ZA 200605478 B ZA200605478 B ZA 200605478B
Authority
ZA
South Africa
Prior art keywords
production
oestrogenic
bioactivity
proliferative
hop extracts
Prior art date
Application number
ZA200605478A
Other languages
English (en)
Inventor
Maes Francis
De Keukeleire Denis
Heyerick Arne
Original Assignee
Biodynamics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biodynamics filed Critical Biodynamics
Publication of ZA200605478B publication Critical patent/ZA200605478B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA200605478A 2003-12-16 2004-12-15 Production of hop extracts having oestrogenic and anti-proliferative bioactivity ZA200605478B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03447290A EP1543834A1 (en) 2003-12-16 2003-12-16 Production of hop extracts having oestrogenic and antiproliferative bioactivity

Publications (1)

Publication Number Publication Date
ZA200605478B true ZA200605478B (en) 2009-05-27

Family

ID=34486584

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200605478A ZA200605478B (en) 2003-12-16 2004-12-15 Production of hop extracts having oestrogenic and anti-proliferative bioactivity

Country Status (18)

Country Link
US (2) US20070110835A1 (es)
EP (2) EP1543834A1 (es)
JP (2) JP5606660B2 (es)
CN (1) CN1893963B (es)
AT (1) ATE429924T1 (es)
AU (1) AU2004298294B2 (es)
CA (1) CA2549662C (es)
DE (1) DE602004020930D1 (es)
DK (1) DK1727555T3 (es)
ES (1) ES2326375T3 (es)
MX (1) MXPA06006782A (es)
NZ (1) NZ548296A (es)
PL (1) PL1727555T3 (es)
PT (1) PT1727555E (es)
RU (1) RU2370273C2 (es)
UA (1) UA86607C2 (es)
WO (1) WO2005058336A1 (es)
ZA (1) ZA200605478B (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0825506B1 (en) 1996-08-20 2013-03-06 Invensys Systems, Inc. Methods and apparatus for remote process control
AU5025600A (en) 1999-05-17 2000-12-05 Foxboro Company, The Process control configuration system with parameterized objects
US7089530B1 (en) 1999-05-17 2006-08-08 Invensys Systems, Inc. Process control configuration system with connection validation and configuration
US6788980B1 (en) 1999-06-11 2004-09-07 Invensys Systems, Inc. Methods and apparatus for control using control devices that provide a virtual machine environment and that communicate via an IP network
US8168234B2 (en) 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US7901713B2 (en) 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7901714B2 (en) 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US8206753B2 (en) 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
MXPA05004288A (es) 2002-10-21 2005-08-02 Metaproteomics Llc Composiciones para tratar o inhibir los estados patologicos asociados con la respuesta inflamatoria.
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
CA2587539A1 (en) * 2004-11-13 2006-05-18 Metaproteomics, Llc Compositions exhibiting inhibition of cyclooxygenase-2
DE102005013258B3 (de) * 2005-03-22 2006-10-12 Hopsteiner-Hallertauer Hopfenveredelungsgesellschaft M.B.H. Verfahren zur Herstellung von Naringeninderivaten aus Xanthohumol
AU2012204133B2 (en) * 2005-08-09 2013-09-19 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
US8263139B2 (en) 2005-08-09 2012-09-11 Metaproteonics, Llc Protein kinase modulation by hops and Acacia products
WO2007053915A2 (en) * 2005-11-09 2007-05-18 Universiteit Gent Naringenin derivatives with selectivity on ers
DE102006018988B3 (de) * 2006-04-25 2007-08-09 Nateco2 Gmbh & Co. Kg Verfahren zur Herstellung eines Xanthohumol-haltigen Pulvers hoher Reinheit und dessen Verwendung
EP1958628A1 (en) * 2007-02-16 2008-08-20 KAIROSmed GmbH Combination of immediately liberated drospirenone with a modified releasing formulation containing 8-prenylnaringenin for use in oral contraception and hormone replacement therapy
EP1920777B1 (de) * 2006-11-13 2011-09-07 Aslieh Dr. Nookandeh-Baumgärtner Extraktionsverfahren zur klassifizierten Gewinnung und Trennung von pflanzlichen Inhaltsstoffen und deren Verwendung
WO2008068344A2 (en) * 2006-12-07 2008-06-12 Inbev S.A. Spent hop products, their content in stilbenes and their use as antioxidant for comestible production
DE102006062264A1 (de) 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
WO2008140842A1 (en) 2007-05-11 2008-11-20 Metaproteomics, Llc Methods and compositions for heavy metal detoxification
PL2187899T3 (pl) * 2007-08-15 2013-11-29 Flaxan Gmbh & Co Kg Wzbogacony w ksantohumol chmielowy ekstrakt
US8142821B2 (en) 2007-08-15 2012-03-27 Flazan GmbH & Co. KG Xanthohumol-enriched hop extract
CN101574398B (zh) * 2008-05-09 2011-04-27 上海信谊百路达药业有限公司 啤酒花提取物及其制备方法与应用
US8594814B2 (en) 2008-06-20 2013-11-26 Invensys Systems, Inc. Systems and methods for immersive interaction with actual and/or simulated facilities for process, environmental and industrial control
FR2940089B1 (fr) * 2008-12-24 2011-03-18 Greenpharma Sas Procede de preparation d'un produit enrichi en flavonoides a partir d'un materiel vegetal
US8127060B2 (en) 2009-05-29 2012-02-28 Invensys Systems, Inc Methods and apparatus for control configuration with control objects that are fieldbus protocol-aware
US8463964B2 (en) 2009-05-29 2013-06-11 Invensys Systems, Inc. Methods and apparatus for control configuration with enhanced change-tracking
EP2392325A1 (en) 2010-06-04 2011-12-07 Universitätsklinikum Münster Compounds for the prevention and/or treatment of osteoarthrosis
CN102115772B (zh) * 2010-12-16 2012-11-14 浙江大学 微生物细胞催化异黄腐酚合成8-异戊烯基柚皮素的方法
CN102911033A (zh) * 2011-08-02 2013-02-06 苏州宝泽堂医药科技有限公司 一种从啤酒花中制备黄腐酚的方法
WO2013022357A1 (en) 2011-08-08 2013-02-14 Uniwersytet Medyczny W Lodzi Polyphenolic formulation, its preparation and use
CN103371989A (zh) * 2012-04-24 2013-10-30 华东师范大学 黄腐酚在制备抑制破骨细胞分化和蚀骨功能的预防和/或治疗药物中的应用
WO2014025989A1 (en) * 2012-08-10 2014-02-13 Eric Hauser Kuhrts Compositions and methods for treating mood disorders or skin disease or damage
CN103254054B (zh) * 2013-05-08 2015-03-04 浙江大学 一种具有癌症预防作用的化合物及其制备方法
PL223580B1 (pl) 2013-10-04 2016-10-31 Bioactive Tech Spółka Z Ograniczoną Odpowiedzialnością Sposób otrzymywania ksantohumolu o wysokiej czystości
DE102013017165A1 (de) * 2013-10-16 2015-04-16 Eberhard Karls Universität Tübingen Medizinische Fakultät Zusammensetzung zur Immunmodulation
CZ307451B6 (cs) * 2014-12-16 2018-09-05 Vysoká škola chemicko-technologická v Praze Způsob přípravy chmelového materiálu se zvýšeným obsahem 8-prenylnaringeninu a chmelový materiál
US20180193287A1 (en) 2015-07-02 2018-07-12 John I. Haas, Inc. Hops-based substance and use of the substance
CN107337661A (zh) * 2016-11-30 2017-11-10 南昌大学 一种从啤酒花中提取8‑异戊二烯基‑4,5,7‑三羟黄烷酮的方法
US10758579B2 (en) 2016-12-07 2020-09-01 Metagreen Ventures Systems and methods for extraction of natural products
PL242648B1 (pl) * 2017-06-30 2023-04-03 Bioactive Tech Spolka Z Ograniczona Odpowiedzialnoscia Sposób otrzymywania ksantohumolu
CA3107838A1 (en) 2018-07-30 2020-02-06 Unilever Global Ip Limited Compositions comprising active botanical ingredients
US20210401918A1 (en) * 2018-11-23 2021-12-30 Naturetech Co. Ltd. Composition comprising combination of red clover extract and hops extract for improvement of menopausal disorder
WO2021089840A1 (en) 2019-11-08 2021-05-14 Mrm Health N.V. Fermentation method for the production of phytoestrogens
CA3225379A1 (en) * 2021-07-09 2023-01-12 Devrim ARAN Prenylated chalcone and flavonoid compositions for use in treating cancer
CN115650942A (zh) * 2022-10-25 2023-01-31 长沙市惠瑞生物科技有限公司 从啤酒花中提取分离纯化8-异戊烯基柚皮素的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3607298A (en) * 1967-04-11 1971-09-21 Bush Boake Allen Ltd Hop concentrates
GB1274678A (en) * 1968-11-19 1972-05-17 Bush Boake Allen Ltd Hop extracts
GB1246425A (en) * 1970-03-02 1971-09-15 Pfizer Preparation of hop extract
US3839588A (en) * 1971-07-12 1974-10-01 Commw Scient Ind Res Org Process of preparing hop extracts
GB1423129A (en) * 1971-08-04 1976-01-28 Bush Boake Allen Ltd Isomerised hop extracts
DE2613593A1 (de) * 1975-04-02 1976-10-21 Dev Tech Centre Rech Verfahren zur behandlung von hopfen
DD290661A5 (de) * 1989-12-22 1991-06-06 Veb Wtoez Der Brau- Und Malzindustrie,De Verfahren zur herstellung von vorisomerisiertem hopfenextrakt
ATE170919T1 (de) * 1992-06-04 1998-09-15 Steiner Inc S S Herstellung von isomerisiertem hopfenextrakt
JPH09301915A (ja) * 1996-05-08 1997-11-25 Sankyo Co Ltd フラボン及びナフタレン誘導体
JP4374123B2 (ja) * 2000-08-08 2009-12-02 アサマ化成株式会社 食品用防腐剤および食品の防腐方法
AU770436B2 (en) * 2000-09-22 2004-02-19 Unilever Plc Use of prenylated flavones
GB0027769D0 (en) * 2000-11-14 2000-12-27 Unilever Plc Cosmetic method of treating skin
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
DE10139479A1 (de) * 2001-08-10 2003-02-27 Schwabe Willmar Gmbh & Co Hopfenextrakte, Verfahren zu ihrer Herstellung und Verwendung
US7144590B2 (en) * 2003-01-09 2006-12-05 Lipoprotein Technologies, Inc. Bioactive compositions derived from humulus lupulus

Also Published As

Publication number Publication date
AU2004298294A1 (en) 2005-06-30
AU2004298294B2 (en) 2011-05-26
JP5606660B2 (ja) 2014-10-15
US20070110835A1 (en) 2007-05-17
ES2326375T3 (es) 2009-10-08
NZ548296A (en) 2009-09-25
DK1727555T3 (da) 2009-08-17
UA86607C2 (ru) 2009-05-12
CN1893963A (zh) 2007-01-10
MXPA06006782A (es) 2007-01-26
CA2549662A1 (en) 2005-06-30
CN1893963B (zh) 2010-09-29
US20110130447A1 (en) 2011-06-02
RU2006125437A (ru) 2008-01-27
EP1543834A1 (en) 2005-06-22
JP2007513982A (ja) 2007-05-31
JP2012254085A (ja) 2012-12-27
WO2005058336A1 (en) 2005-06-30
PT1727555E (pt) 2009-08-05
RU2370273C2 (ru) 2009-10-20
CA2549662C (en) 2014-02-11
ATE429924T1 (de) 2009-05-15
EP1727555A1 (en) 2006-12-06
EP1727555B1 (en) 2009-04-29
DE602004020930D1 (de) 2009-06-10
PL1727555T3 (pl) 2009-10-30

Similar Documents

Publication Publication Date Title
ZA200605478B (en) Production of hop extracts having oestrogenic and anti-proliferative bioactivity
IL181200A0 (en) Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom
HUP0303002A3 (en) Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
HK1062901A1 (en) Processes for preparing a cannabinoid-rich extract from cannabis plant material
ATE307126T1 (de) Extraktion von flavonoiden
WO2002024002A3 (en) Food supplement
AU2002218242A1 (en) Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
AU8859301A (en) Efficient method for producing compositions enriched in anthocyanins
TW200515878A (en) Flavored smokeless tobacco and methods of making
MXPA03008630A (es) Derivados de arilisoxazolinas, procedimientos para su preparacion y su utilizacion como agentes plaguicidas.
IL165037A0 (en) Low isoflavones, high saponins soy product and process for producing the same
EP1491099A4 (en) METHOD FOR PRODUCING SWITCHING DIAGRAM AND THESE FOODS AND BEVERAGES CONTAINING THEREOF
MXPA03010322A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE POLIISOCIANATOS.
FR2784104B1 (fr) Procede de preparation de la vitamine e
MXPA03006478A (es) Derivados de cromano, procedimiento para su preparacion y su uso como agentes antitumorales.
WO2005054222A3 (de) Flavonoid-derivat
WO2005034648A3 (en) Method for the production of pending natural botanical extracts
UA87114C2 (ru) Способ получения экстракта из листьев плюща, экстракт, его применение и лекарственное средство
ZA200308166B (en) Extraction process.
MXPA03004537A (es) Derivados sustituidos con ciclohexano y uso de los mismos en medicamentos para tratar enfermedades cardiovasculares.
WO2004006831A3 (en) Method and device for inducing biological processes by micro-organs
DE602004013762D1 (de) Basidiomyzeten, basidiomyzetenextraktzusammensetzung sowie reformkost und immunopotentiatoren
MXPA03006501A (es) Producto alimenticio cremoso y metodo para su eleboracion.
WO2004065396A3 (de) Phosphorsäureester von polyisobuten-substituierten aromatischen hydroxyverbindungen
EP1569169A4 (en) VIDEO SYSTEM